nps-568 has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckmann, J; Bloch, J; Gross, ML; Hettgen, V; Hoemme, M; Li, L; Mueller, J; Mundel, P; Oh, J; Penzel, R; Schaefer, F; Schmitt, CP | 1 |
1 other study(ies) available for nps-568 and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis.
Topics: Aniline Compounds; Animals; Calcimimetic Agents; Cell Survival; Cytoskeleton; Glomerulosclerosis, Focal Segmental; Phenethylamines; Podocytes; Propylamines; Rats; Receptors, Calcium-Sensing | 2011 |